Clinical study - Sein métastatique HER2+

Sein métastatique HER2+
Ouvert depuis le: 09.25.2022
Site: Paris
Ouvert depuis le: 04.25.2022
Site: Saint-Cloud
Public cible
Analysis of Circulating Tumor Markers in Blood
Description de l'essai

The circulating tumoral biomarkers in the blood are the object of numerous researches for several decades. The potential clinical interests of these circulating biomarkers are diagnostic, prognostic, predictive of the efficiency of targeted therapies (according to the mutational profile of the cancer), and could allow the study of the mechanisms of resistance under process. In the multiplicity of these blood potential biomarkers joins a permanent evolution of the technological means used to detect them/to quantify, as well as to estimate their clinical utility.